Sun Pharma Revital H Woman ads misleading, inadequately substantiated: ASCI Medical Dialogues Bureau4 Sept 2019 5:18 PM ISTNew Delhi: Country's largest drugmaker, Sun Pharmaceuticals Ltd, (Sun Pharma) has been pulled up by the Advertising Standards Council of India (ASCI)...
Lupin, Boehringer Ingelheim sign USD 700 million deal for novel oncology drug Farhat Nasim4 Sept 2019 5:00 PM ISTLupin will receive an upfront payment of $20 million and potential additional payments for successful achievement of defined clinical, regulatory and...
Sandoz to commercialize biosimilar of MS drug Natalizumab Medical Dialogues Bureau4 Sept 2019 9:45 AM ISTUnder the agreement, Sandoz will commercialize and distribute natalizumab biosimilar in all markets upon approval, through an exclusive global...
Former JnJ executive Marianne De Backer to lead Bayer pharma division Medical Dialogues Bureau4 Sept 2019 9:30 AM ISTMarianne De Backer will take the role of Head of Business Development & Licensing at Bayer's pharmaceuticals division, joining from rival JnJ,...
Vertex Pharma, Semma enter deal worth USD 950 million to develop treatments for diabetes Medical Dialogues Bureau4 Sept 2019 9:15 AM ISTThe deal represents Vertex Pharma's foray into a new treatment space, as the company typically develops treatments for cystic fibrosis, an inherited...
Purdue Pharma prepares free-fall bankruptcy as settlement talks halt: Report Medical Dialogues Bureau4 Sept 2019 9:00 AM ISTU.S: OxyContin maker Purdue Pharma LP is preparing to seek bankruptcy protection before the end of the month if it does not reach a settlement with...
Zydus Cadila wins DCGI nod for marketing rabies drug Twinrab Medical Dialogues Bureau3 Sept 2019 10:00 AM IST"The novel biologic which will be marketed under the brand name, Twinrab, is indicated in combination with rabies vaccine for rabies post-exposure...
Novartis, Lonza strengthen biosimilars push with MS, arthritis drug deals Medical Dialogues Bureau3 Sept 2019 9:30 AM ISTNovartis's Sandoz generics unit, among the biggest biosimilars makers, on Tuesday, agreed to license from Poland's Polpharma Biologics a version of...
Roche Xofluza shows promise in reducing risk of developing flu by 86pc Medical Dialogues Bureau3 Sept 2019 9:05 AM IST"Xofluza is the first and only one-dose oral medicine approved to treat flu in otherwise healthy patients, and the first new flu medicine with a novel...
China expansion of drug bulk-buy programme puts pressure on pharma companies Medical Dialogues Bureau3 Sept 2019 9:00 AM ISTThe programme rolled out last year saw 11 Chinese cities, including Beijing and Shanghai, band together behind a tender process to bulk-buy 25 types...
Sanofi revival depends on outsider with nose for big drugs: Report Medical Dialogues Bureau3 Sept 2019 8:58 AM ISTDefining Sanofi's ambitions in the cutting-edge field of gene therapies and figuring out whether to hold on to consumer health brands are among other...
DOP junks Cipla plea to refix MRP of Tafmune–EM Farhat Nasim2 Sept 2019 4:34 PM ISTNew Delhi: Through a recent decision, the Department of Pharmaceuticals (DOP) has rejected the review application filed by Cipla Limited against...
